Found 5 matching trials
Immunotherapy of Melanoma Patients
PHASE1The purpose of this study is to test whether vaccination with antigenic pep...
Location
Ludwig Institute for Cancer Research + Multidisciplinary Oncology Center at the Centre Hospitalier Universitaire Vaudois
Immunotherapy of Stage III/IV Melanoma Patients
PHASE1The purpose of this study is to determine whether vaccination with melanoma...
Location
Oncology Department, Lausanne University Hospital (CHUV) and University of Lausanne
Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients
PHASE1The purpose of this study is to determine whether vaccination with tumor an...
Location
Ludwig Institute for Cancer Research + Multidisciplinary Oncology Center at the Centre Hospitalier Universitaire Vaudois
Adoptive Cell Transfer Combined With Peptide Vaccination in Transiently Immunosuppressed Melanoma Patients
PHASE1Patients with advanced stage melanoma who underwent vaccination with the Me...
Location
Multidisciplinary Oncology Center, University of Lausanne Hospitals
Vaccine Therapy and GM-CSF With or Without Low-Dose Aldesleukin in Treating Patients With Stage II, Stage III, or Stage IV Melanoma
PHASE1RATIONALE: Vaccines made from peptides may help the body build an effective...